Histone Deacetylase 4: The Epigenetic Hub in Degenerative Musculoskeletal Diseases
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Aging has rendered Degenerative Musculoskeletal Diseases (DMDs) an increasingly significant public health burden. Growing evidence suggests that epigenetic dysregulation plays a crucial mechanistic role in the pathogenesis of DMDs. Histone Deacetylase 4 (HDAC4), known for its regulatory roles in the nervous, cardiovascular, and cancer systems, has also emerged as a central coordinator of musculoskeletal physiology and pathology. It dynamically modulates cellular metabolism in cartilage, bone, and muscle tissues. This review aims to provide a comprehensive overview of current research on HDAC4 in the context of DMDs, highlighting its roles in chondrocyte homeostasis, synovial inflammation, osteoblast-osteoclast balance, and muscle fiber atrophy. Furthermore, we explore the therapeutic potential of targeting HDAC4 for the treatment of musculoskeletal diseases, including osteoarthritis, osteoporosis, and muscle atrophy.
Fields of Study & Subjects
Osteoarthritis Treatment and Mechanisms
Histone Deacetylase Inhibitors Research
Bone Metabolism and Diseases
Publication details
- Journal / source
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Volume
- 26
- Pages
- e18715303416616–e18715303416616
- Publication date
- 30 March 2026
- Language
- EN